Neusoft Medical's self-developed NeuSpace multimodal intelligent imaging post-processing platform and its CT-focused AI software NeuSpace.CT have both received NMPA market approval. The platform supports hospital deployment and multi-terminal access through intelligent imaging output, second-level image analysis, quality control and risk alerts, and full-cycle patient services; NeuSpace.CT is powered by a multimodal large-model engine covering 44 diseases, 78 applications and 6 imaging modalities, with a built-in 'Lingyu' bio-cognitive compression engine that can compress 200GB of data to 20GB.